This week PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, M&A, Biosimilars, Animal Health & Biotech. Check out our full report below:
Novartis Reports Data from P-III (STEER) Study of Onasemnogene Abeparvovec to Treat Children and Young Adults with Spinal Muscular Atrophy (SMA)
Read More: Novartis
CARsgen Therapeutics Reports Topline Results from P-II…
Shots:
PettureX has reported the launch of its AI-based health scanning app, PettureX App, available through app stores in Jan 20, 2025, to enhance pet health monitoring
The app enables pet owners detect health issues early through guided smartphone image scans of eyes, skin, or teeth. The AI provides real-time assessments and care recommendations,…
Shots:
The WHO’s One Health policy is driving innovation in animal health, emphasizing the intersection of human, animal, and environmental care
The global animal health market, valued at $62.4B in 2023, is expected to grow at a CAGR of 9%, reaching $114B by 2030
PharmaShots presents a comprehensive report on the Top 20 Animal Health Companies of…
Shots:
With 2.7B cases of illness and 2.5M deaths annually, containing zoonotic diseases remains a major challenge for researchers, scientists, and healthcare professionals. Diseases originating from animals account for an alarming 60 percentÂ
Animal health fosters a holistic approach to disease prevention in animals by containing unforeseen diseases beforehand. The animal health industry was valued…
Humans depends on livestock for survival and Animal Health has always been an issue to look for since it directly reflects the betterment of human life
For a country’s economy and balanced human life, proper care and disease-free health of animals play a key role. Since rapid environmental change has targeted animal health, it becomes…

